Alliance Global Partners Initiates Coverage On Evogene With Buy Rating, Announces Price Target of $1.85
Alliance Global Partners Initiates Coverage On Evogene With Buy Rating, Announces Price Target of $1.85
Alliance Global Partners以買入評級開始對Evogene進行報道，宣佈目標股價爲1.85美元
Alliance Global Partners analyst Ben Haynor initiates coverage on Evogene (NASDAQ:EVGN) with a Buy rating and announces Price Target of $1.85.
Alliance Global Partners分析師Ben Haynor在納斯達克(EVGN)上以買入評級啟動對Evogene的報道，並宣佈目標價為1.85美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。